243 related articles for article (PubMed ID: 18274997)
1. Diethylene-triamine-penta-acetate administration protocol for radiological emergency medicine in nuclear fuel reprocessing plants.
Jin Y
Hemoglobin; 2008; 32(1-2):199-206. PubMed ID: 18274997
[TBL] [Abstract][Full Text] [Related]
2. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
Taylor DM; Hodgson SA; Stradling N
Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
[TBL] [Abstract][Full Text] [Related]
3. AN ACCIDENT OF INTERNAL CONTAMINATION WITH PLUTONIUM AND AMERICIUM AT A NUCLEAR FACILITY IN JAPAN: A PRELIMINARY REPORT AND THE POSSIBILITY OF DTPA ADMINISTRATION ADDING TO THE DIAGNOSIS.
Tatsuzaki H; Tominaga T; Kim E; Watanabe S; Tsutsumi Y; Sagara M; Takada C; Momose T; Kurihara O; Akashi M
Radiat Prot Dosimetry; 2018 Dec; 182(1):98-103. PubMed ID: 30165696
[TBL] [Abstract][Full Text] [Related]
4. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
[TBL] [Abstract][Full Text] [Related]
5. Successful DTPA therapy in the case of 239Pu penetration via injured skin exposed to nitric acid.
Khokhryakov VF; Belyaev AP; Kudryavtseva TI; Schadilov AE; Moroz GS; Shalaginov VA
Radiat Prot Dosimetry; 2003; 105(1-4):499-502. PubMed ID: 14527017
[TBL] [Abstract][Full Text] [Related]
6. Calcium and zinc DTPA administration for internal contamination with plutonium-238 and americium-241.
Kazzi ZN; Heyl A; Ruprecht J
Curr Pharm Biotechnol; 2012 Aug; 13(10):1957-63. PubMed ID: 22352730
[TBL] [Abstract][Full Text] [Related]
7. Treatment of actinide exposures: a review of Ca-DTPA injections inside CEA-COGEMA plants.
Grappin L; Berard P; Menetrier F; Carbone L; Courtay C; Castagnet X; Le Goff JP; Neron MO; Piechowski J
Radiat Prot Dosimetry; 2007; 127(1-4):435-9. PubMed ID: 17940101
[TBL] [Abstract][Full Text] [Related]
8. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
[TBL] [Abstract][Full Text] [Related]
9. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological properties and clinical efficacy of pentetate calcium trisodium and pentetate zinc trisodium, antidotes for transuranium elements].
Abe T
Nihon Yakurigaku Zasshi; 2012 Jan; 139(1):33-8. PubMed ID: 22230879
[No Abstract] [Full Text] [Related]
11. Preferential decorporation of americium by pulmonary administration of DTPA dry powder after inhalation of aged PuO(2) containing americium in rats.
Grémy O; Tsapis N; Chau Q; Renault D; Abram MC; Van der Meeren A
Radiat Res; 2010 Nov; 174(5):637-44. PubMed ID: 20726717
[TBL] [Abstract][Full Text] [Related]
12. Chelation Treatment by Early Inhalation of Liquid Aerosol DTPA for Removing Plutonium after Rat Lung Contamination.
Miccoli L; Ménétrier F; Laroche P; Grémy O
Radiat Res; 2019 Dec; 192(6):630-639. PubMed ID: 31545678
[TBL] [Abstract][Full Text] [Related]
13. A case of wound intake of plutonium isotopes and 241Am in a human: application and improvement of the NCRP wound model.
Schadilov AE; Belosokhov MV; Levina ES
Health Phys; 2010 Oct; 99(4):560-7. PubMed ID: 20838099
[TBL] [Abstract][Full Text] [Related]
14. Design and functionalities of the MADOR® software suite for dose-reduction management after DTPA therapy.
Leprince B; Fritsch P; Bérard P; Roméo PH
Radiat Prot Dosimetry; 2016 Mar; 168(3):350-7. PubMed ID: 25999333
[TBL] [Abstract][Full Text] [Related]
15. Aerosolization of Zn-DTPA Decorporation Agent Using Jet and Ultrasonic Nebulizers.
Mehri R; Tang W; Matida EA; Lai EPC
J Aerosol Med Pulm Drug Deliv; 2018 Oct; 31(5):311-320. PubMed ID: 29641361
[TBL] [Abstract][Full Text] [Related]
16. Risks and management of radiation exposure.
Yamamoto LG
Pediatr Emerg Care; 2013 Sep; 29(9):1016-26; quiz 1027-29. PubMed ID: 24201986
[TBL] [Abstract][Full Text] [Related]
17. Influence of DTPA Treatment on Internal Dose Estimates.
Davesne E; Blanchardon E; Peleau B; Correze P; Bohand S; Franck D
Health Phys; 2016 Jun; 110(6):551-7. PubMed ID: 27115221
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat.
Miller SC; Liu G; Bruenger FW; Lloyd RD
Radiat Prot Dosimetry; 2006; 118(4):412-20. PubMed ID: 16332916
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic removal of internally deposited transuranium elements.
Smith VH
Health Phys; 1972 Jun; 22(6):765-78. PubMed ID: 5084009
[No Abstract] [Full Text] [Related]
20. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
